Presence of Embolic Source and Outcome in Central Retinal Artery Occlusion.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 37400246.
- Also identified by DOI 10.1212/WNL.0000000000207445 and PMC identifier 10558162.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The etiology of central retinal artery occlusion (CRAO) is unclear in approximately 50% of patients, suggesting pathomechanical heterogeneity; moreover, little is known about outcomes according to etiology. This study investigated whether the presence of an embolic source affects outcome in CRAO. CRAO patients within 7 days of symptom onset were retrospectively enrolled. Clinical parameters, including initial and 1-month visual acuity, CRAO subtype, and brain images, were reviewed. CRAO etiology was categorized as CRAO with or without an embolic source (CRAO-E<sup>+</sup> and CRAO-E<sup>-</sup>). Visual improvement was defined as a decrease in logarithm of the minimum angle of resolution ≥0.3 at 1 month. A total of 114 patients with CRAO were included. Visual improvement was noted in 40.4% of patients. Embolic sources were identified in 55.3% of patients, and visual improvement group rather than no improvement group was more commonly associated with the presence of an embolic source. In multivariable logistic regression analysis, CRAO-E<sup>+</sup> independently predicted visual improvement (odds ratio 3.00, 95% CI 1.15-7.81, <i>p</i> = 0.025). CRAO-E<sup>+</sup> was found to be associated with a better outcome. CRAO-E<sup>+</sup> may be more prone to recanalization than that CRAO-E<sup>-</sup>.
Medical subject headings
- Retinal Artery Occlusion
- Embolism